Global Influenza Vaccine Market Insights, Forecast to 2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,900	158 Pages	QYResearch Group	April, 2022	QYR17072470

Best Price Guarantee
Price	from $4,900
Length	158 Pages
Publisher	QYResearch Group
Published Date	April, 2022
SKU	QYR17072470

Global Influenza Vaccine Market Insights, Forecast to 2028

Summary

Market Analysis and Insights: Global Influenza Vaccine Market
Due to the COVID-19 pandemic, the global Influenza Vaccine market size is estimated to be worth US$ 8036 million in 2022 and is forecast to a readjusted size of US$ 10952 million by 2028 with a CAGR of 5.3% during the review period.

The global key manufacturers of Influenza Vaccine include CSL, GSK, Sanofi, Viatris, Hualan Bio, AstraZeneca, Changchun Institute of Biological, etc. In 2021, the global top five players have a share approximately 85.04% in terms of revenue.

Global Influenza Vaccine Scope and Segment
Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years

Segment by Region
North America
U.S.
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia

Europe
Germany
France
U.K.
Italy
Russia

South America
Brazil

Middle East & Africa
Middle East
Africa

1 STUDY COVERAGE: 1.1 Influenza Vaccine Product Introduction; 1.2 Market by Type; 1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028; 1.2.2 Trivalent Influenza Vaccine; 1.2.3 Quadrivalent Influenza Vaccine; 1.3 Market by Application; 1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028; 1.3.2 For Children (6 months to 3 years); 1.3.3 For Adults and Children over 3 years; 1.4 Study Objectives; 1.5 Years Considered
2 EXECUTIVE SUMMARY: 2.1 Global Influenza Vaccine Sales Estimates and Forecasts 2017-2028; 2.2 Global Influenza Vaccine Revenue Estimates and Forecasts 2017-2028; 2.3 Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028; 2.4 Global Influenza Vaccine Sales by Region; 2.4.1 Global Influenza Vaccine Sales by Region (2017-2022); 2.4.2 Global Sales Influenza Vaccine by Region (2023-2028); 2.5 Global Influenza Vaccine Revenue by Region; 2.5.1 Global Influenza Vaccine Revenue by Region (2017-2022); 2.5.2 Global Influenza Vaccine Revenue by Region (2023-2028); 2.6 North America; 2.7 Europe; 2.8 Asia-Pacific; 2.9 South America; 2.10 Middle East & Africa
3 COMPETITION BY MANUFACTURERS: 3.1 Global Influenza Vaccine Sales by Manufacturers; 3.1.1 Global Influenza Vaccine Sales by Manufacturers (2020-2022); 3.1.2 Global Influenza Vaccine Sales Market Share by Manufacturers (2020-2022); 3.1.3 Global Top Largest Manufacturers of Influenza Vaccine in 2021; 3.2 Global Influenza Vaccine Revenue by Manufacturers; 3.2.1 Global Influenza Vaccine Revenue by Manufacturers (2020-2022); 3.2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2020-2022); 3.2.3 Global Top Companies by Influenza Vaccine Revenue in 2021; 3.3 Global Influenza Vaccine Sales Price by Manufacturers (2020-2022); 3.4 Analysis of Competitive Landscape; 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI); 3.4.2 Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3); 3.4.3 Global Influenza Vaccine Manufacturers Geographical Distribution; 3.5 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE: 4.1 Global Influenza Vaccine Sales by Type; 4.1.1 Global Influenza Vaccine Historical Sales by Type (2017-2022); 4.1.2 Global Influenza Vaccine Forecasted Sales by Type (2023-2028); 4.1.3 Global Influenza Vaccine Sales Market Share by Type (2017-2028); 4.2 Global Influenza Vaccine Revenue by Type; 4.2.1 Global Influenza Vaccine Historical Revenue by Type (2017-2022); 4.2.2 Global Influenza Vaccine Forecasted Revenue by Type (2023-2028); 4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2017-2028); 4.3 Global Influenza Vaccine Price by Type; 4.3.1 Global Influenza Vaccine Price by Type (2017-2022); 4.3.2 Global Influenza Vaccine Price Forecast by Type (2023-2028)
5 MARKET SIZE BY APPLICATION: 5.1 Global Influenza Vaccine Sales by Application; 5.1.1 Global Influenza Vaccine Historical Sales by Application (2017-2022); 5.1.2 Global Influenza Vaccine Forecasted Sales by Application (2023-2028); 5.1.3 Global Influenza Vaccine Sales Market Share by Application (2017-2028); 5.2 Global Influenza Vaccine Revenue by Application; 5.2.1 Global Influenza Vaccine Historical Revenue by Application (2017-2022); 5.2.2 Global Influenza Vaccine Forecasted Revenue by Application (2023-2028); 5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2017-2028); 5.3 Global Influenza Vaccine Price by Application; 5.3.1 Global Influenza Vaccine Price by Application (2017-2022); 5.3.2 Global Influenza Vaccine Price Forecast by Application (2023-2028)
6 NORTH AMERICA: 6.1 North America Influenza Vaccine Market Size by Type; 6.1.1 North America Influenza Vaccine Sales by Type (2017-2028); 6.1.2 North America Influenza Vaccine Revenue by Type (2017-2028); 6.2 North America Influenza Vaccine Market Size by Application; 6.3 North America Influenza Vaccine Sales by Country; 6.3.1 North America Influenza Vaccine Sales by Country (2017-2028); 6.3.2 North America Influenza Vaccine Revenue by Country (2017-2028); 6.3.3 U.S.; 6.3.4 Canada; 6.3.5 Mexico
7 EUROPE: 7.1 Europe Influenza Vaccine Market Size by Type; 7.1.1 Europe Influenza Vaccine Sales by Type (2017-2028); 7.1.2 Europe Influenza Vaccine Revenue by Type (2017-2028); 7.2 Europe Influenza Vaccine Market Size by Application; 7.3 Europe Influenza Vaccine Market Size by Country; 7.3.1 Europe Influenza Vaccine Sales by Country (2017-2028); 7.3.2 Europe Influenza Vaccine Revenue by Country (2017-2028); 7.3.3 Germany; 7.3.4 France; 7.3.5 U.K.; 7.3.6 Italy; 7.3.7 Russia
8 ASIA PACIFIC: 8.1 Asia Pacific Influenza Vaccine Market Size by Type; 8.1.1 Asia Pacific Influenza Vaccine Sales by Type (2017-2028); 8.1.2 Asia Pacific Influenza Vaccine Revenue by Type (2017-2028); 8.2 Asia Pacific Influenza Vaccine Market Size by Application; 8.3 Asia Pacific Influenza Vaccine Market Size by Region; 8.3.1 Asia Pacific Influenza Vaccine Sales by Region (2017-2028); 8.3.2 Asia Pacific Influenza Vaccine Revenue by Region (2017-2028); 8.3.3 China; 8.3.4 Japan; 8.3.5 South Korea; 8.3.6 India; 8.3.7 Australia; 8.3.8 Southeast Asia
9 SOUTH AMERICA: 9.1 South America Influenza Vaccine Market Size by Type; 9.1.1 South America Influenza Vaccine Sales by Type (2017-2028); 9.1.2 South America Influenza Vaccine Revenue by Type (2017-2028); 9.2 South America Influenza Vaccine Market Size by Application; 9.3 South America Influenza Vaccine Market Size by Country; 9.3.1 South America Influenza Vaccine Sales by Country (2017-2028); 9.3.2 South America Influenza Vaccine Revenue by Country (2017-2028); 9.3.3 Brazil
10 MIDDLE EAST AND AFRICA: 10.1 Middle East and Africa Influenza Vaccine Market Size by Type; 10.1.1 Middle East and Africa Influenza Vaccine Sales by Type (2017-2028); 10.1.2 Middle East and Africa Influenza Vaccine Revenue by Type (2017-2028); 10.2 Middle East and Africa Influenza Vaccine Market Size by Application; 10.3 Middle East and Africa Influenza Vaccine Market Size by Country; 10.3.1 Middle East and Africa Influenza Vaccine Sales by Country (2017-2028); 10.3.2 Middle East and Africa Influenza Vaccine Revenue by Country (2017-2028); 10.3.3 Middle East; 10.3.4 Africa
11 CORPORATE PROFILE: 11.1 Sanofi; 11.1.1 Sanofi Corporation Information; 11.1.2 Sanofi Overview; 11.1.3 Sanofi Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.1.4 Sanofi Influenza Vaccine Product Introduction; 11.1.5 Sanofi Recent Developments; 11.2 CSL; 11.2.1 CSL Corporation Information; 11.2.2 CSL Overview; 11.2.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.2.4 CSL Influenza Vaccine Product Introduction; 11.2.5 CSL Recent Developments; 11.3 GSK; 11.3.1 GSK Corporation Information; 11.3.2 GSK Overview; 11.3.3 GSK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.3.4 GSK Influenza Vaccine Product Introduction; 11.4 Viatris; 11.4.1 Viatris Corporation Information; 11.4.2 Viatris Overview; 11.4.3 Viatris Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.4.4 Viatris Influenza Vaccine Product Introduction; 11.4.5 Viatris Recent Developments; 11.5 AstraZeneca; 11.5.1 AstraZeneca Corporation Information; 11.5.2 AstraZeneca Overview; 11.5.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.5.4 AstraZeneca Influenza Vaccine Product Introduction; 11.5.5 AstraZeneca Recent Developments; 11.6 Hualan Bio; 11.6.1 Hualan Bio Corporation Information; 11.6.2 Hualan Bio Overview; 11.6.3 Hualan Bio Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.6.4 Hualan Bio Influenza Vaccine Product Introduction; 11.7 Changchun Institute of Biological; 11.7.1 Changchun Institute of Biological Corporation Information; 11.7.2 Changchun Institute of Biological Overview; 11.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.7.4 Changchun Institute of Biological Influenza Vaccine Product Introduction; 11.7.5 Changchun Institute of Biological Recent Developments; 11.8 Sinovac; 11.8.1 Sinovac Corporation Information; 11.8.2 Sinovac Overview; 11.8.3 Sinovac Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.8.4 Sinovac Influenza Vaccine Product Introduction; 11.8.5 Sinovac Recent Developments; 11.9 BCHT; 11.9.1 BCHT Corporation Information; 11.9.2 BCHT Overview; 11.9.3 BCHT Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.9.4 BCHT Influenza Vaccine Product Introduction; 11.9.5 BCHT Recent Developments; 11.10 Jiangsu GDK; 11.10.1 Jiangsu GDK Corporation Information; 11.10.2 Jiangsu GDK Overview; 11.10.3 Jiangsu GDK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.10.4 Jiangsu GDK Influenza Vaccine Product Introduction; 11.11 KM Biologics; 11.11.1 KM Biologics Corporation Information; 11.11.2 KM Biologics Overview; 11.11.3 KM Biologics Influenza Vaccine Sales, Price, Revenue and Gross Margin (2020-2022); 11.11.4 KM Biologics Influenza Vaccine Product Introduction; 11.11.5 KM Biologics Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS: 12.1 Influenza Vaccine Industry Chain Analysis; 12.2 Influenza Vaccine Key Raw Materials; 12.2.1 Key Raw Materials; 12.2.2 Raw Materials Key Suppliers; 12.3 Influenza Vaccine Production Mode & Process; 12.4 Influenza Vaccine Sales and Marketing; 12.4.1 Influenza Vaccine Sales Channels; 12.4.2 Influenza Vaccine Distributors; 12.5 Influenza Vaccine Customers
13 INFLUENZA VACCINE MARKET DYNAMICS: 13.1.1 Influenza Vaccine Industry Trends; 13.1.2 Influenza Vaccine Market Drivers; 13.1.3 Influenza Vaccine Market Challenges; 13.1.4 Influenza Vaccine Market Restraints
14 KEY FINDINGS IN THE GLOBAL INFLUENZA VACCINE STUDY
15 APPENDIX: 15.1 Research Methodology; 15.1.1 Methodology/Research Approach; 15.1.2 Data Source; 15.2 Author Details; 15.3 Disclaimer; List of Tables; Table 1. Global Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million); Table 2. Major Manufacturers of Quadrivalent Influenza Vaccine; Table 3. Global Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million); Table 4. Global Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million); Table 5. Global Influenza Vaccine Sales by Region (2017-2022) & (M Doses); Table 6. Global Influenza Vaccine Sales Market Share by Region (2017-2022); Table 7. Global Influenza Vaccine Sales by Region (2023-2028) & (M Doses); Table 8. Global Influenza Vaccine Sales Market Share by Region (2023-2028); Table 9. Global Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million); Table 10. Global Influenza Vaccine Revenue Market Share by Region (2017-2022); Table 11. Global Influenza Vaccine Revenue by Region (2023-2028) & (US$ Million); Table 12. Global Influenza Vaccine Revenue Market Share by Region (2023-2028); Table 13. Global Influenza Vaccine Sales by Manufacturers (2020-2022) & (M Doses); Table 14. Global Influenza Vaccine Sales Share by Manufacturers (2020-2022); Table 15. Global Influenza Vaccine Revenue by Manufacturers (2020-2022) & (US$ Million); Table 16. Global Influenza Vaccine Revenue Market Share by Manufacturers (2020-2022); Table 17. Influenza Vaccine Price by Manufacturers (2020-2022) & (USD/Doses)